Jr. Gruber et al., RETINOIC ACID SPECIFICALLY INCREASES NUCLEAR PKC-ALPHA AND STIMULATESAP-1 TRANSCRIPTIONAL ACTIVITY IN B16 MOUSE MELANOMA-CELLS, Experimental cell research, 221(2), 1995, pp. 377-384
B16 melanoma cells differentiate upon treatment with retinoic acid (RA
), This differentiation process is accompanied by an increase of prote
in kinase C alpha (PKC alpha) mRNA and protein levels, Overexpression
of PKC alpha in these cells results in a more differentiated phenotype
, suggesting the importance of this protein in the control of differen
tiation by Rk The purpose of the study reported here was to determine
the subcellular distribution of the RA-induced PKC alpha, whether the
RA-induced increase in PKC alpha protein levels was accompanied by an
increase in in situ enzyme activity, and whether RA altered AP-I trans
criptional activity, We found that RA treatment increased PKC alpha pr
otein levels in all subcellular compartments examined, but it also ind
uced a selective enrichment in nuclear-associated PKC alpha levels, Tr
eating cells with an active phorbol ester induced translocation of PKC
alpha to membrane fractions, but had no effect on nuclear PKC alpha l
evels, RA also increased PKC enzymatic activity in intact cells as det
ermined by phosphorylation of the PKC-specific endogenous substrate MA
RCKS, However, while RA induced a five- to eightfold increase in total
cellular PKC alpha protein levels, it only increased MARCKS phosphory
lation by twofold. In light of the increase in in situ PMC enzyme acti
vity and the enrichment of nuclear PKC alpha, We determined whether AP
-1 activity might be increased in RA-treated cells. Use of luciferase
reporter gene constructs with or without AP-1 elements transfected int
o B16 cells indicated that RA induced a four- to fivefold increase in
AP-1 transcriptional activity, These results suggest a hypothesis wher
eby RA-induced nuclear PKC alpha might lead to increased AP-1 activity
and show that RA-induced growth inhibition and differentiation are no
t always accompanied by an inhibition of AP-1 activity as has been pro
posed by other investigators. (C) 1995 Academic Press, Inc.